Détail de l'auteur
Auteur Gidaro T |
Documents disponibles écrits par cet auteur



![]()
Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study
Annoussamy M, Seferian AM, Daron A, et al.
Annals of clinical and translational neurology, 2020
Revue : Annals of clinical and translational neurology Titre : Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study Type de document : Article Auteurs : Annoussamy M ; Seferian AM ; Daron A ; Pereon Y ; Cances C ; Vuillerot C ; De Waele L ; Laugel V ; Schara U ; Gidaro T ; Lilien C ; Hogrel JY ; Carlier P ; Fournier E ; Lowes L ; Gorni K ; Ly-Le Moal M ; Hellbach N ; Seabrook T ; Czech C ; Hermosilla R ; Servais L Editeur : United States Année de publication : 24/12/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 33369268 / DOI : 10.1002/acn3.51281
N° Profil MNM : 2020123 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/33369268 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseases
Reyngoudt H, Marty B, Boisserie JM, et al.
European radiology, 2020
Revue : European radiology Titre : Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseases Type de document : Article Auteurs : Reyngoudt H ; Marty B ; Boisserie JM ; Le Louër J ; Koumako C ; Baudin PY ; Wong B ; Stojkovic T ; Behin A ; Gidaro T ; Allenbach Y ; Benveniste O ; Servais L ; Carlier PG Editeur : Germany Année de publication : 21/11/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 33219846 / DOI : 10.1007/s00330-020-07487-0
N° Profil MNM : 2020112 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/33219846 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy
Previtali SC, Gidaro T, Diaz-Manera J, et al.
Pharmacological Research, 2020, 104999
Revue : Pharmacological Research Titre : Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy Type de document : Article Auteurs : Previtali SC ; Gidaro T ; Diaz-Manera J ; Zambon A ; Carnesecchi S ; Roux-Lombard P ; Spitali P ; Signorelli M ; Szigyarto CA ; Johansson C ; Gray J ; Labolle D ; Porte Thome F ; Pitchforth J ; Domingos J ; Muntoni F Editeur : Netherlands Année de publication : 06/2020 Pages : 104999 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32535224 / DOI : 10.1016/j.phrs.2020.104999
N° Profil MNM : 2020061 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32535224 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Normalized grip strength is a sensitive outcome measure through all stages of Duchenne muscular dystrophy
Hogrel JY, Decostre V, Ledoux I, et al.
Journal of neurology, 2020
Revue : Journal of neurology Titre : Normalized grip strength is a sensitive outcome measure through all stages of Duchenne muscular dystrophy Type de document : Article Auteurs : Hogrel JY, Auteur ; Decostre V ; Ledoux I ; De Antonio M ; Niks EH ; De Groot I ; Straub V ; Muntoni F ; Ricotti V ; Voit T ; Seferian A ; Gidaro T ; Servais L Editeur : Germany Année de publication : 03/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32206900 / DOI : 10.1007/s00415-020-09800-9
N° Profil MNM : 2020032 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32206900 Voir aussiAvis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Quantitative nuclear magnetic resonance imaging detects subclinical changes over 1 year in skeletal muscle of GNE myopathy
Gidaro T, Reyngoudt H, Le Louër J, et al.
Journal of neurology, 2020, 267, 1, p 228
Revue : Journal of neurology, 267, 1 Titre : Quantitative nuclear magnetic resonance imaging detects subclinical changes over 1 year in skeletal muscle of GNE myopathy Type de document : Article Auteurs : Gidaro T ; Reyngoudt H ; Le Louër J ; Behin A ; Toumi F ; Villeret M ; Araujo ECA ; Baudin PY ; Marty B ; Annoussamy M ; Hogrel JY ; Carlier PG ; Servais L Editeur : Germany Année de publication : 2020 Pages : p 228 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 31616990 / DOI : 10.1007/s00415-019-09569-6
En ligne : http://www.ncbi.nlm.nih.gov/pubmed/31616990 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Relationship between markers of disease activity and progression in skeletal muscle of GNE myopathy patients using quantitative nuclear magnetic resonance imaging and (31)P nuclear magnetic resonance spectroscopy
Reyngoudt H, Marty B, Caldas de Almeida Araujo E, et al.
Quantitative imaging in medicine and surgery, 2020, 10, 7, p 1450
Permalink![]()
ASC-1 Is a Cell Cycle Regulator Associated with Severe and Mild Forms of Myopathy
Villar-Quiles RN, Catervi F, Cabet E, et al.
Annals of neurology, 2019
Permalink![]()
Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen
Aragon-Gawinska K, Daron A, Ulinici A, et al.
Developmental medicine and child neurology, 2019
Permalink![]()
Home-Based Monitor for Gait and Activity Analysis
Lilien C, Gasnier E, Gidaro T, et al.
Journal of visualized experiments : JoVE, 2019, n 150
Permalink![]()
X-linked myotubular myopathy: A prospective international natural history study
Annoussamy M, Lilien C, Gidaro T, et al.
Neurology, 2019, 92, 16
Permalink![]()
Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps
Gidaro T, Gidaro T, Servais L
Developmental medicine and child neurology, 2019, 61, 1, p 19
Permalink![]()
Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: A cohort study.
Aragon-Gawinska K, Seferian AM, Daron A, et al.
Neurology, 2018, e1312
Permalink![]()
Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study.
Chabanon A, Seferian AM, Daron A, et al.
PLoS ONE, 2018, e0201004
Permalink![]()
Targeted exomes reveal simultaneous MFN2 and GDAP1 mutations in a severe Charcot-Marie-Tooth disease type 2 phenotype
Anghelescu C, Francou B, Cardas R, et al.
European journal of neurology, 2017, 24, 3, p e15
Permalink![]()
Improved Muscular Weakness During Asthma Exacerbation
Delstanche S, Servais L, Gidaro T
JAMA Neurology, 2017, 74, 3, p 353
Permalink![]()
DMD and West syndrome
Cardas R, Iliescu C, Butoianu N, et al.
Neuromuscular disorders : NMD, 2017, 27, 10, p 911
Permalink![]()
First experience of Nusinersen early access program in patients with spinal muscular atrophy type 1
Gargaun E, Aragon-Gawinska K, Seferian A, et al.
Neuromuscular disorders : NMD, 2017, 27, s2, S211
Permalink![]()
Safety, tolerability and clinical efficacy of nusinersen in SMA type 1 older than 7 months: a prospective study
Aragon-Gawinska K, Gargaun E, Seferian A, et al.
Neuromuscular disorders : NMD, 2017, 27, s2, s211
Permalink![]()
EGR2 mutation enhances phenotype spectrum of Dejerine-Sottas syndrome
Gargaun E, Seferian AM, Cardas R, et al.
Journal of neurology, 2016, 263, 7, p 1456
Permalink![]()
Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy
Hogrel JY, Wary C, Moraux A, et al.
Neurology, 2016, 86, 11, p 1022
Permalink![]()
Mild clinical presentation in KLHL40-related nemaline myopathy (NEM 8)
Seferian AM, Malfatti E, Bosson C, et al.
Neuromuscular disorders : NMD, 2016, 26, 10, p 712
Permalink![]()
Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1
Bachasson D, Moraux A, Ollivier G, et al.
Neuromuscular disorders : NMD, 2016, 26, 7, p 428
Permalink![]()
Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing
Klein P, Oloko M, Roth F, et al.
Nucleic acids research, 2016, 44, 22, p 10929
Permalink![]()
Mitochondrial Dysfunction reveals the role of mRNA Poly(A) tail regulation in Oculopharyngeal muscular dystrophy pathogenesis
Chartier A, Klein P, Pierson S, et al.
PLoS Genetics, 2015, 1005092, p. 1-27
Permalink![]()
PABPN1 (GCN)11 as a dominant allele in Oculopharyngeal Muscular Dystrophy - Consequences in clinical diagnosis and genetic counselling
Richard P, Trollet C, Gidaro T, et al.
Journal of Neuromuscular Diseases, 2015, 2, 2, p 175
Permalink